Cargando…
Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Background: Surgical resection offers the best chance of survival in patients with pancreatic cancer, but those with locally advanced disease (LAPC) are usually not surgical candidates. This cohort often receives either neoadjuvant chemotherapy or chemoradiation (CRT), but unintended weight loss cou...
Autores principales: | Naumann, Patrick, Eberlein, Jonathan, Farnia, Benjamin, Hackert, Thilo, Debus, Jürgen, Combs, Stephanie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562489/ https://www.ncbi.nlm.nih.gov/pubmed/31126040 http://dx.doi.org/10.3390/cancers11050709 |
Ejemplares similares
-
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
por: Naumann, Patrick, et al.
Publicado: (2019) -
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012) -
A review of weight loss and sarcopenia in patients with head and neck cancer treated with chemoradiation
por: Baxi, Shrujal S., et al.
Publicado: (2016) -
Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection
por: Habermehl, Daniel, et al.
Publicado: (2013) -
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)